TGF-β signaling in cancer -: a double-edged sword

被引：519

作者：

Akhurst, RJ ^{[1
]}

Derynck, R

机构：

[1] Univ Calif San Francisco, Mt Zion Canc Res Inst, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Dept Growth & Dev, Cell Biol Program, San Francisco, CA 94143 USA

[3] Univ Calif San Francisco, Dept Growth & Dev, Program Dev Biol, San Francisco, CA 94143 USA

[4] Univ Calif San Francisco, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA

[5] Univ Calif San Francisco, Dept Growth & Dev, Program Dev Biol, San Francisco, CA 94143 USA

来源：

TRENDS IN CELL BIOLOGY | 2001年 / 11卷 / 11期

关键词：

D O I：

10.1016/S0962-8924(01)02130-4

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Transforming growth factor (TGF) beta1 is a potent growth inhibitor, with tumor-suppressing activity. Cancers are often refractile to this growth inhibition either because of genetic loss of TGF-beta signaling components or, more commonly, because of downstream perturbation of the signaling pathway, such as by Ras activation. Carcinomas often secrete excess TGF-beta1 and respond to it by enhanced invasion and metastasis. Therapeutic approaches should aim to inhibit the TGF-beta -induced invasive phenotype, but also to retain its growth-inhibitory and apoptosis-inducing effects.

引用

页码：S44 / S51

页数：8

共 78 条

[1] Elevated levels of circulating interleukin-6 and transforming growth factor-β1 in patients with metastatic prostatic carcinoma [J].

Adler, HL ;

McCurdy, MA ;

Kattan, MW ;

Timme, TL ;

Scardino, PT ;

Thompson, TC .

JOURNAL OF UROLOGY, 1999, 161 (01) :182-187

[2] LOCALIZED PRODUCTION OF TGF-BETA MESSENGER-RNA IN TUMOR PROMOTER-STIMULATED MOUSE EPIDERMIS [J].

AKHURST, RJ ;

FEE, F ;

BALMAIN, A .

NATURE, 1988, 331 (6154) :363-365

[3]

Ananth S, 1999, CANCER RES, V59, P2210

[4] Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-β [J].

Arteaga, CL ;

Koli, KM ;

Dugger, TC ;

Clarke, R .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (01) :46-53

[5] ANTI-TRANSFORMING GROWTH-FACTOR (TGF)-BETA ANTIBODIES INHIBIT BREAST-CANCER CELL TUMORIGENICITY AND INCREASE MOUSE SPLEEN NATURAL-KILLER-CELL ACTIVITY - IMPLICATIONS FOR A POSSIBLE ROLE OF TUMOR-CELL HOST TGF-BETA INTERACTIONS IN HUMAN BREAST-CANCER PROGRESSION [J].

ARTEAGA, CL ;

HURD, SD ;

WINNIER, AR ;

JOHNSON, MD ;

FENDLY, BM ;

FORBES, JT .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2569-2576

[6] Endoglin, an ancillary TGFβ receptor, is required for extraembryonic angiogenesis and plays a key role in heart development [J].

Arthur, HM ;

Ure, J ;

Smith, AJH ;

Renforth, G ;

Wilson, DI ;

Torsney, E ;

Charlton, R ;

Parums, DV ;

Jowett, T ;

Marchuk, DA ;

Burn, J ;

Diamond, AG .

DEVELOPMENTAL BIOLOGY, 2000, 217 (01) :42-53

[7]

Bandyopadhyay A, 1999, CANCER RES, V59, P5041

[8]

BATTIFORA H, 1976, CANCER, V37, P2275, DOI 10.1002/1097-0142(197605)37:5<2275::AID-CNCR2820370518>3.0.CO

[9]

2-3

[10] The activin receptor-like kinase 1 gene: Genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2 [J].

Berg, JN ;

Gallione, CJ ;

Stenzel, TT ;

Johnson, DW ;

Allen, WP ;

Schwartz, CE ;

Jackson, CE ;

Porteous, MEM ;

Marchuk, DA .

AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (01) :60-67

← 1 2 3 4 5 6 7 8 →